Vidita Vaidya awarded Infosys Prize 2022 in Life Sciences
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
The unit will have installed manufacturing capacity of over 15 million vials annually that includes lyophilized vials, all in the anti-cancer segment
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
Collaboration to implement AbTis’ AbClick platform into Lonza’s bioconjugation toolbox
The pharma laboratory is fully equipped with all the machinery needed to support formulation development, resolve technical challenges, and provide customer demonstrations
The core of “LANXESS Biosecurity Solutions” is a portfolio of scientifically formulated, highly effective and versatile biocidal products
H1 FY23 revenues at Rs. 860.1 crore, higher by 40% YoY whereas PAT at Rs. 52.6 crore, higher by 4% YoY
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
ADCelerate delivers Phase I appropriate antibody-drug conjugate (ADC) drug substance and drug product for Investigational New Drug (IND) submission
The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited and its agreed parties
Subscribe To Our Newsletter & Stay Updated